In Indonesia, leprosy remains a health problem because its elimination has not achieved. This shows the high Mycobacterium leprae transmission as a result of difficulties in the early detection, termination of the transmission chain, and management evaluation. Integrated translational research has been carried out as a solution for the problem. Dissemination of the various results of the research is conducted by the educational aspects tiered with a variety of learning methods including a textbook based on research findings, scientific papers at various scientific meetings, and published journals, as well as aspects of community service through electronic media, newspapers, and management and counseling with leprosy patients and their contact person, especially in endemic pockets area.
Introduction
Leprosy (Morbus Hansen) is a chronic infectious disease caused by bacteria Mycobacterium leprae, which primarily affects the peripheral nerves, and secondary attacks the skin and other organs. World Health Organization (WHO) classified leprosy into two types: paucibacillary (PB), which is relatively not contagious, and multibacillary (MB), which have infectious potential. Complications that occur in leprosy [erythema nodosum leprosum (ENL)] can cause disability in patients resulting in decreased quality of life.
In Indonesia, leprosy remains a health problem. Indonesia has the third-highest number of leprosy patients in the world after India and Brazil, the discovery of new cases is relatively stable from year to year, the dominance of the type of MB (potentially infectious) causes disability (9.9%) and can strike children (7.8%) thus affecting the future of the nation buds. This and specificity. Detecting M. leprae by biotechnology based on biomolecular aspect requires laboratories facility and analysts. This method has been performed only in research areas in Indonesia. The advantage of this method is more accurate than the routine method. Its accuracy is important for early detection of leprosy.
Detection of DNA M. leprae using PCR
The presence of M. leprae in the blood of patient with subclinical leprosy is still a question mark [1] . The answer should be taken into account by considering the management of subclinical leprosy, because subclinical leprosy has the potency of manifest leprosy and be the source of transmission. M. leprae DNA in the blood of subclinical leprosy patient, was investigated using polymerase chain reaction (PCR) test. This study took place in two leprosy endemic villages named Kombang and Poteran in Talango Island of Sumenep District, Madura, East Java, Indonesia. After dermatologic examinations of 122 people with leprosy contact, venous blood was collected to estimate the seropositivity to various mycobacterial antigens. The antiphenolic glycolipid (antiPGL-1) IgM antibody was measured by indirect ELISA.
In those 122 patients with leprosy contact, we found 29 people who had >600 U/ml antiPGL-1 IgM antibody refer to subclinical leprosy (Figure 1 ). From 29 subclinical leprosy patients, we collected 2 ml of venous blood and extracted M. leprae DNA using TaKaRa GenTLE methods ( Figure 2 ) followed by the PCR test using nested primer Lp1-Lp4 from RLEP repetitive sequence (Figure 3) .
The result of this study is expected to be important for the management of patients with subclinical leprosy. Considering the potential to manifest into leprosy and become a source of transmission, therefore, we suggest that using new preventive measures such as chemoprophylaxis for high risk groups is important to control the spread of leprosy. Detecting viable M. leprae is still a problem due to the uncultivable characteristics of the bacilli [2] . A new biomolecular technique of RNA isolation is now used for the detection of viable M. leprae, since RNA is rapidly degraded upon cell death. The reverse transcriptase polymerase chain reaction (RT-PCR) method for detecting 16 ribosomal RNA subunit (16S rRNA) M. leprae can be used as viable sign of M. leprae. 16S rRNA M. leprae denoting housekeeping gene containing specific and unique 1170 nucleotide sequence having specific structure variants and were relatively abundant with 1000-10,000 copies in one bacteria with specific characteristic and will be soon degraded after the death of M. leprae. Thus, 16S rRNA study by RT-PCR could reflect M. leprae viability with high sensitivity and specificity.
We detected 16S rRNA M. leprae from skin biopsy and blood of new leprosy patients and to 
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improve the weakness of skin tissue biopsy sample which was invasive and did not take into account the comfortability of the patient. Skin biopsy and peripheral blood mononuclear cells (PBMCs) were obtained from 24 newly diagnosed (14 male and 10 female) untreated leprosy patients in Dr Soetomo Hospital, Surabaya. Diagnosis is based on clinical and AFB examinations. Informed consent was signed beforehand by all of the patients. RNA isolation, cDNA synthesis, conventional PCR, and real-time PCR using primer set P2 (forward, 69-91) and P3 (reverse, 218-239) were performed in all samples (Figures 4 and 5) .
In skin biopsy and blood from both MB and PB leprosy, 16S rRNA M. leprae can be detected, showing a systemic process that occurred. Reverse transcription methods using conventional PCR and real-time PCR has better sensitivity than AFB staining (Figure 6 ). Detecting viable M. leprae by reverse transcription methods may prove to be useful in early detection of leprosy and the potency of transmission, also assessing the efficacy of treatment and potency source of relapse.
The failure of phagolysosome process as a marker viability
Phagolysosome process in macrophage of leprosy patients is important in the early phase of eliminating M. leprae invasion [3] . This study was done to clarify the involvement of Rab5, Rab7, and trytophan aspartate-containing coat protein (TACO) from host macrophage and leprae lipoarabinomannan (Lep-LAM) and phenolic glycolipid-1 (PGL-1) from M. leprae cell wall as the reflection of phagolysosome process in relation to 16 subunit ribosomal RNA Table 1 . Mann-Whitney U test results of the differences in the expression of Rab5, Rab7, tryptophan aspartate-containing coat protein (TACO), leprae lipoarabinomannan (Lep-LAM), and phenolic glycolipid-1 (PGL-1) based on positive and negative viability with p = 0.05. phagolysosome failure was also found from the study. Hence, the expression profiles of Rab5, Rab7, Lep-LAM, and PGL-1 can be used as markers of M. leprae viability. From these discoveries, an early diagnostic method for leprosy based on expression pro-files of Rab5, Rab7,
Lep-LAM, and PGL-1 is possible. Early diagnosis in leprosy cases is very useful to prevent the occurrence of disability or transmission. In addition to the above discoveries, it is important to study the expression profiles of Rab5, Rab7, Lep-LAM, and PGL-1 in peripheral blood mononuclear cells (PBMCs). Based on the research done by the Leprosy Study Group of the Institute of Tropical Disease, Universitas Airlangga (Prakoeswa, 2011), the results showed no significant differences between expression profiles of 16S rRNA of M. leprae in skin biopsy tissue and PBMCs using real-time PCR. Therefore, from the study, the expression profiles of Rab5, Rab7, Lep-LAM, and PGL-1 in PBMCs can be explored to be used as a base. Blood tests without skin biopsy may be sufficient enough and used to create a simplified and noninvasive early diagnostic marker tool for leprosy viability.
Based on the three studies above, early diagnostic method for leprosy can be performed suited to the condition of the facility involved. In a highly qualified laboratorium with skilled analysts, DNA and RNA tests can be performed whereas in a laboratorium with limited facility and analysts, Immunohistochemistry (IHC) test may be used instead based on the phagolysosome failure process.
Management of leprosy
There has been a decrease in the number of new leprosy patient after MDTL era. However, the number of new cases found is still relatively stable. This means that interventions are still needed to evaluate, and measures to be taken to manage leprosy cases.
Dapsone and rifampicin resistance
Drug resistant cases can be tested by using the biomolecular method as an alternate solution as it is relatively simpler and less time consuming [4] . Based on the detection of mutation in folp and rpoB gene, we conducted a study about the prevalence of M. leprae drug resistance to dapsone and rifampicin in East Java. DNA templates from 153 isolates obtained from MB leprosy patients from East Java were processed. Polymerase chain reaction (PCR) test was initiated using Lp1-Lp4 primer to show the presence of M. leprae. The folP and rpoB genes were amplified using folP1-folPR and rpoBF-rpoBR primers to obtain the DNA sequence target with 59 isolates for folP gene study and 94 isolates for rpoB gene study. After purification of PCR product, DNA sequencing was initiated to analyze the mutation on nucleotide sequence.
All isolates showed positive PCR results by Lp1-Lp4. From 59 isolates, 50 isolates showed positive PCR results by folP1-folPR ( Figure 12A ) and the same result goes by rpoBF-rpoBR from 77 out of 94 isolates ( Figure 12B) . In folP gene examination, no mutation was found in rpoB gene ( Figure 13A ). There are 3 isolates out of 53 that were found to have mutation in amino acid at codon 53; two cases where threonine (ACC) became alanine (GCC) ( Figure 13B and C), and in one case threonine (ACC) became arginin (AGA) ( Figure 13D ). This mutation held responsible for the resistance of M. leprae to dapsone. The result suggested that three isolates (6%) from East Java-Indonesia in this experiment are resistant to dapsone and all isolates (100%) are sensitive to rifampicin.
Surprisingly, from three cases that show mutations in the folP gene, one of them is a new case with 1 month of multidrug treatment (MDT) duration time. The electropherogram of this sample can be seen in Figure 13D . The mutation was detected in amino acid at codon 53 (157-159 nucleotides that are from "ACC" (threonine) to "AGA" (arginine). The isolate is regarded to as a primary diaminodiphenyl sulfone (DDS) resistant. Another mutation in amino acid at codon 53 (157-159 nucleotides) that was detected in two samples is from "ACC" (threonine) to "GCC" (alanine). Based on the clinical data, these two samples are suspected resistant to DDS.
Methylsulfonylmethane treatment in erythema nodosum leprosum
Erythema nodosum leprosum (ENL) is a complex reaction found in the immune system [5] . It causes antibody-antigen complexes to be deposited within various tissues and may cause vasculitis. This condition may occur in MB leprosy patients. While the immunopathology of this disease is not fully understood, the reaction is known as a tumor necrosis factor-α (TNF-α)- are limited with high level of morbidity and chronicity. Previous study showed that methylsulfonylmethane (MSM) has strong capability as antiTNF-α properties in vitro. This means that MSM might be useful for treating TNF-α-mediated conditions, such as ENL reaction. Hence, the objective of this study is to establish a correlation whether MSM is effective to treat the clinical signs and symptoms of recurrent ENL reaction in MB leprosy patients.
In this study, patients eligible for the study were all those with MB and admitted for at least a second episode of severe ENL reaction. A total of 10 patients who were eligible for the inclusion and exclusion criteria were enrolled for the study. A standardized history taking using a checklist was recorded from all of the patients chosen for the study. Thorough physical examination was done to look for skin signs, motoric or sensory neuropathy signs, and other possible complications of ENL. After each examination, ENL reaction severity scale was performed and included the basic neurological examination.
Nerve function assessment includes sensory nerve function using the Semmes-Weinstein monofilament test (MFT) and motor nerve function using voluntary muscle tests (VMTs)
and all impairments will be recorded. Blood (10 ml) was taken for laboratory assessments on day 1, 7, and 63 for TNF-α examination and routine blood assessment on day 1, 7, 14, 56, and 112. MSM was given to the patients in the study with a dose of 0.1 g/kg bodyweight daily in two divided doses in addition to the World Health Organization's (WHO) multidrug treatment (MDT) and/or additional clofazimine, if a patient has already taken it when the new reaction occurred. If the patient shows clinically significant improvement, the dose would be tapered off by 1 g every 2 weeks, starting from 1 week from the start of MSM treatment. Treatment will be stopped completely in 2 weeks after reaching 1 g/day level. Figure 14 . Two out of 10 patients showed improvement from ENL reaction. These patients revealed high level of TNF-α, and this value decreased along with lessening of ENL severity scale. First, patient showed increased ENL severity scale within MSM tapering off (full dose of MSM repeatedly and tapered off). The second patient was still in a good condition during follow-up. Eight other patients were dropped on day 3 and 5. In those eight patients, the value of TNF-α showed to be normal and was excluded from the study due to the increase of ENL severity scale. MFT and VMT examinations showed no changes during the study. This finding proves that MSM treatment modality is possible as drug of choice for ENL patients with high level of TNF-α in concordance to its mechanism of action as an antiTNF-α.
Graphic of TNF-α in 10 patients is shown in

Chemoprophylaxis in subclinical leprosy
Subclinical leprosy is a person who has high titer of IgM antiPGL-1 without clinical manifestation of leprosy that manifests after several years [6] . Preventive treatment of this leprosy is required especially in children in order to prevent manifest toward leprosy and prevent it from spreading. We evaluate the result of 2 years preventive treatment to subclinical leprosy in elementary school children using special regiment rifampicin and clarithromycin in Raas Island and Nguling, East Java, Indonesia.
Serological surveys for leprosy were conducted and involved a total of 5066 school children, who were screened in 2 leprosy endemic locations in East Java. About 302 elementary school children [109 from Nguling ( Figure 15 ) and 193 from Raas Island (Figure 16) ] were positive for sero (+++) with high IgM antiPGL-1 antibody titer (>3000 U/ml ELISA). Rifampicin 300 mg daily with 250 mg clarithromycin daily for 10 days was given as a preventive treatment, continued with the same drugs administered intermittently every 2 weeks for 3 months. Every year, clinical and serological examination was evaluated.
After 2 years evaluation, none of the children showed any manifestation of leprosy clinically. IgM antiPGL-1 antibody level showed to decrease between these 2 years of evaluation (Raas Island and Nguling: p = 0.00). The majority of the children (Raas Island 96.46%; Nguling 94.83%) showed a decrease in IgM antiPGL-1 antibody level, but some of these children (Raas Island 3.54%; Nguling 5.17%) also showed an increased level of IgM antiPGL-1 antibody. All the medications were well tolerated by these children and only a few side effects due to these drugs were reported. Chemoprophylaxis for subclinical leprosy in children showed a promising good result after 2 years of evaluation. Further evaluation will be conducted for the next 3 years ahead. Our research about subclinical leprosy in children may support the clinical importance of it in exploring the disease transmission and how we can prevent it.
From these three studies, evaluation of resistance for suspected cases, MSM administration for refractory cases to steroid and administration of chemoprophylaxis for subclinical leprosy, can be implemented on routine leprosy management. Ongoing research is expected to prevent the onset of leprosy. Study on the impact of chemoprophylaxis in household and neighbor contact person with a grant from the Netherlands Leprosy Relief is also being carried out in collaboration with the Ministry of Health and local government. 
Mode of the transmission
During this time, it is believed that the only source of transmission is leprosy MB type, but as we have not achieved elimination, we begin to think about another source of the transmission.
Strain local study in endemic area using PCR sequencing
Multiple locus variable number of tandem repeat (VNTR) analysis has been proposed as a mean of genotyping for tracking leprosy transmission [7] . Many tandem repeats have been reported to be polymorphic with the potential as genetic markers to differentiate strains of M. leprae.
However, depending on the population, the characteristics of polymorphism may vary. We measured the copy number of repeat in four genetic markers, which are TTC, AC 8a, AC 9, and 6-7 (Figures 17-23) in leprosy patients. A number of 23 patients were recruited from outpatient clinic in Department of Dermato-Venereology of Dr Hasan Sadikin Hospital, Bandung. Multiple locus VNTR analysis at four loci was applied using total DNA extracts from skin biopsies. As shown in Table 3 , there were five samples showing the same copy number of four genetic marker: TTC = 15; AC 8a = 10; AC 9 = 10, and 6-7 = 6. Two samples showing the same copy number of four genetic marker: TTC = 16; AC 8a = 10; AC 9 = 11, and 6-7 = 6. The multiple locus VNTR analysis shows two identical M. leprae VNTR profiles from Bandung. These attributes support the use of VNTR loci for transmission studies and VNTR analysis can use for multicases family study. 
Environment study and multicase family study using PCR sequencing
East Java is a province in Indonesia that has few endemic areas for leprosy [8] . In order to comprehend this increasing incidence of leprosy, molecular typing will make it feasible to study geographical distributions of M. leprae. Genotyping analysis was done by using variable number tandem repeats that found in the rpoT gene which was followed by the recognition of the TTC triplet in a region of the M. leprae genome. The aim of this study is to analyze the number variation of TTC repeats and their distributions in leprosy endemic areas. Poteran Island in Madura was chosen for its high prevalence for leprosy and the number has remained stable for the last 5 years. Samples were collected and divide into 3 groups: 91 water sources;
42 nasal swabs of household contact, and 68 skin tissues of leprosy patients. All samples were analyzed by using PCR (Figure 24 ) and the numbers of TTC repeats were confirmed by direct sequencing. From all collected samples, 24 isolates from water resources were positive (26.4%); 26 nasal swabs were also positive (61.9%); and also 24 skin tissues (35.3%). Table 4 . Genotypes TTC frequency (%).
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The copy number of TTC repeats in Talango Island varied from 9 to 60 copies ( Table 4) . The 11-copy TTC genotype was the most frequent in all samples.
The copy number of TTC repeats in Talango Island varied from 10 to 11 copies ( Table 5 ). The 11-copy TTC genotype was the most frequent in all samples. There were no differences were found statistically in the pattern distribution of TTC repeats between nasal swab of households contacts and skin tissues of patients (p = 0.594); skin tissues of leprosy patients and water resources (p = 0.441); nasal swab of households contact with water resources (p = 0.906). It can be concluded in endemic areas, transmission of M. leprae has strong ties with these three aspects: agent, host, and environment.
Mother-baby transmission in leprosy
Lucio phenomenon is a rare type of reaction in untreated lepromatous leprosy type with diffuse infiltrative form, characterized with ulcerative type of skin lesions [9] . In this study, a case of 29-year-old Indonesian female, 7th month primigravida with lucio leprosy, without prior treatment using WHO-multidrug therapy (MDT). Laboratory examinations reported bacterial index 6+ and morphological index 7% from slit-skin smear; histopathology revealed lucio phenomenon; PCR examination found M. leprae DNA on amniotic fluid and skin lesion: positive; umbilical cord membrane and umbilical cord: negative (Figure 25) . AntiPGL-1 IgM and IgG from patient: 4854 and 1061 U/mL, respectively; from 5-month-old baby: 5 and 1724 U/mL, respectively; from 1-year-old baby: 0 and 3 U/mL, respectively. In Table 6 , patient's antiPGL-1 IgM and IgG titers collected during caesarian section were way over the cutoff limit, whereas the antiPGL-1 IgM and IgG titers from the umbilical cord blood were below the limit. Hence, placenta is regarded as a protective barrier against fetomaternal transmission of M. leprae. The placenta has multiple innate defense properties against pathogens. Only few pathogens can pass through these barriers at low frequencies. DNA of M. leprae was found in the amniotic fluid. About 5% of babies born from Baby (1 year-old) 0 3 Table 6 . Results of serological examination using ELISA.
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mothers with active leprosy had self-limited indeterminate leprosy before 2 years old and also antiwill have M. leprae antibodies of class IgA, IgG, and IgM. The presence of IgA and IgM antiM. leprae antibodies in the cord blood of newborn babies from mothers with leprosy might shows an intrauterine immunologic stimulation process that happened due to transplacental transmission of M. leprae antibodies. Titers for antiPGL-1 IgM and IgG were reviewed again after the babies reached 5 months old and 1-year-old. On assessment, the titers were found to drop drastically, especially antiPGL-1 IgG titer. Based on these facts, we assume that passive antibody to M. leprae from the babies had been acquired from their mothers' blood and transmitted through the umbilical cord blood as shown by the presence of antiPGL-1 IgG antibody.
Studies in genotyping of patients and contact person proved that genotyping is not always appropriate; there is still the possibility of environmental transmission source. From these three studies above, there can be further potential research on transmission of leprosy from nonhuman sources. In the transmission pattern from mother to baby, it shows the importance of the role of placenta as a barrier, therefore, the health of the expecting mother needs to be optimized so as to prevent fetomaternal transmission and to treat the mother as early as possible and closely monitored the baby during incubation phase.
Conclusions
Dissemination of an integrated translational research above is done through aspects: education: lectures, case discussions, bed side teaching, and writing research-based textbook for medical students, undergraduates, postgraduates, and dermatology and venereology residency program. Besides, presentations are done at local and international scientific meetings as well as publication of journals. Research: an integrated translational research is a continuous activity with the ultimate goal to eliminate leprosy in Indonesia. Community services: improving services and counseling at social events as well as when we are doing research in endemic pockets area. Besides, counseling is also done through electronic media. Community services can be done in practice of the research results of what they learned through lectures and case discussions in accordance with the level of competence they need to accomplish.
Various educational activities, research, and community service above increase knowledge about leprosy with the ultimate goal of achieving elimination through improvements in the field of preventive, curative, promotive, and rehabilitative. Here, the role of educational institutions is very important in helping to resolve the national problem. In the future, we hope more collaboration research of diagnosis, management, and mode of transmission will be conducted to overcome the problem of leprosy include early detection, management evaluation, and termination of the transmission chain. Integrated translational research is important to be done to resolve leprosy problems both in the community and clinics during the process of medical education.
